Filing Details

Accession Number:
0001209191-10-025155
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-04 13:00:00
Reporting Period:
2010-04-30
Filing Date:
2010-05-04
Accepted Time:
2010-05-04 17:36:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1171147 G Douglas Watson 3005 First Avenue
Seattle WA 98121
Board Of Director Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-30 28,671 $4.90 54,921 No 4 M Direct
Common Stock Disposition 2010-04-30 28,671 $56.56 26,250 No 4 S Direct
Common Stock Acquisiton 2010-04-30 7,500 $26.64 33,750 No 4 M Direct
Common Stock Disposition 2010-04-30 7,500 $56.56 26,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option(right to buy) Disposition 2010-04-30 28,671 $56.56 28,671 $4.90
Common Stock Non-Qualified Stock Option(right to buy) Disposition 2010-04-30 7,500 $56.56 7,500 $26.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-12-05 No 4 M Direct
0 2019-12-08 No 4 M Direct
Footnotes
  1. All options are exercisable on date of grant.